MedCap
  • Home
  • About MedCap
    • About MedCap
    • Mission and Objectives
    • Investment Strategy
    • MedCap as an Owner
    • Board of Directors
    • Management
  • Operations
    • Operations
    • MedTech Business Area
    • Specialty Pharma Business Area
    • Acquisition History
  • Investors
    • Investors
    • MedCap as an Investment
    • The Share
      • Share Data
      • Changes in Share Capital
      • Shareholder Structure
      • Insider Trading
      • Analysts and Market Makers
      • Dividend Policy
    • Financial Information
      • Interim Reports
      • Prospectus
      • Annual Reports
      • Presentations
      • Financial Targets
      • Investor Policy
      • IR Calendar
      • IR Contacts
      • Definitions
      • Accounting Policies
      • Key Figures
    • Corporate Governance
      • Corporate Governance Report
      • Articles of Association
      • General Meeting
      • Nomination Committee
      • Board Duties
      • Committees
      • Board Remuneration
      • Internal Controls
      • Management Duties
      • Remuneration
      • Auditors
    • Calendar
  • Sustainability
  • GDPR
  • Media
    • Media
    • Press Releases
      • Regulatory Press Releases
      • None-Regulatory Press Releases
    • Request Information
  • Contact
  • Search

Board remuneration

Fees and other remuneration to directors, including the chairman, shall be approved by the annual general meeting. The annual general meeting of 13 May 2019 resolved that directors’ fees shall amount to SEK 400 thousand for the chairman and SEK 150 thousand for each other director. The above fees are remuneration for a period of one year. In agreement with MedCap, directors may invoice their fees, provided that prevailing legislation, through a company and the invoiced fees shall consequently be determined so as to be cost-neutral for MedCap. In addition, directors are not entitled to any remuneration in connection with the termination of their duties.

Remuneration in financial year 2018

The table below presents an overview of remuneration paid to the current directors of MedCap in financial year 2018.

SEKk Director’s fee/basic salary/
consultant fee (ex. VAT)
Defined-contribution pension costs Variable remuneration Total
Michael Berg 300 – – 300
Anders Hansen 107 – – 107
Henrik Blomquist 117 – – 117
Henrik Stenqvist 137 – – 137
Renée Aguiar-Lucander 107 – – 107
Summa styrelsen 768 0 0 768
  • Investors
  • MedCap as an Investment
  • The Share
    • Share Data
    • Changes in Share Capital
    • Shareholder Structure
    • Insider Trading
    • Analysts and Market Makers
    • Dividend Policy
  • Financial Information
    • Interim Reports
    • Prospectus
    • Annual Reports
    • Presentations
    • Financial Targets
    • Investor Policy
    • IR Calendar
    • IR Contacts
    • Definitions
    • Accounting Policies
    • Key Figures
  • Corporate Governance
    • Corporate Governance Report
    • Articles of Association
    • General Meeting
    • Nomination Committee
    • Board Duties
    • Committees
    • Board Remuneration
    • Internal Controls
    • Management Duties
    • Remuneration
    • Auditors
  • Calendar
  • About MedCap
  • Mission and Objectives
  • Investment Strategy
  • MedCap as an Owner
  • Board of Directors
  • Management
  • Operations
  • MedTech Business Area
  • Specialty Pharma Business Area
  • Acquisition History
  • Investors
  • Investors
  • The Share
  • Financial Information
  • Corporate Governance
  • Calendar
  • Media
  • Press Releases
  • Request Information
  • Image Archive
  • Contact
MedCap AB | Sundbybergsvägen 1 | 171 73 Solna | +46 8 34 71 10 | info@medcap.se
Scroll to top